Table 6 Chronic GVHD outcome of patient... | American Society of Hematology

Table 6

Chronic GVHD outcome of patient cohort

	1 year	2 years	P
Chronic GVHD (extensive)	32.3 (25.3-41.3)	33.1 (26.0-42.1)
Donor
Related	51.5 (40.9-64.8)	51.5 (40.9-64.8)
Unrelated	12.3 (6.4-23.6)	13.8 (7.6-25.4)	.001**
GVHD prophylaxis
CsA/MMF	30.0 (22.6-39.9)	30.9 (23.4-40.9)
CsA/mMTX	43.5 (27.3-69.3)	43.5 (27.3-69.3)	.53*

	1 year	2 years	P
Chronic GVHD (extensive)	32.3 (25.3-41.3)	33.1 (26.0-42.1)
Donor
Related	51.5 (40.9-64.8)	51.5 (40.9-64.8)
Unrelated	12.3 (6.4-23.6)	13.8 (7.6-25.4)	.001**
GVHD prophylaxis
CsA/MMF	30.0 (22.6-39.9)	30.9 (23.4-40.9)
CsA/mMTX	43.5 (27.3-69.3)	43.5 (27.3-69.3)	.53*

Data are percentages (ranges) of patients.

CI indicates 95% confidence interval.

Univariate analysis (Cox proportional hazards regression models).

Multivariate analysis (Cox proportional hazards regression models).